BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8344336)

  • 1. Influence of platelet size before coronary angioplasty on subsequent restenosis.
    Smyth DW; Martin JF; Michalis L; Bucknall CA; Jewitt DE
    Eur J Clin Invest; 1993 Jun; 23(6):361-7. PubMed ID: 8344336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of haematological parameters before coronary angioplasty on subsequent restenosis.
    Avci A; Boyaci A; Cağli K; Cosgun A; Gokce V; Duru E; Korkmaz S
    Acta Cardiol; 2004 Jun; 59(3):263-8. PubMed ID: 15255457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris.
    Yang A; Pizzulli L; Lüderitz B
    Thromb Res; 2006; 117(4):371-7. PubMed ID: 15935453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.
    Chu SG; Becker RC; Berger PB; Bhatt DL; Eikelboom JW; Konkle B; Mohler ER; Reilly MP; Berger JS
    J Thromb Haemost; 2010 Jan; 8(1):148-56. PubMed ID: 19691485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of restenosis after successful coronary angioplasty: improved clinical decision making with use of a logistic model combining procedural and follow-up variables.
    Renkin J; Melin J; Robert A; Richelle F; Bachy JL; Col J; Detry JM; Wijns W
    J Am Coll Cardiol; 1990 Nov; 16(6):1333-40. PubMed ID: 2229783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which angiographic variable best describes functional status 6 months after successful single-vessel coronary balloon angioplasty?
    Rensing BJ; Hermans WR; Deckers JW; de Feyter PJ; Serruys PW
    J Am Coll Cardiol; 1993 Feb; 21(2):317-24. PubMed ID: 8425992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
    Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregability and occurrence of restenosis following coronary angioplasty.
    Goel PK; Shahi M; Agarwal AK; Srivastava S; Seth PK
    Int J Cardiol; 1997 Aug; 60(3):227-31. PubMed ID: 9261632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Rensing BJ; Foley DP; Deckers JW; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Am Coll Cardiol; 1992 Oct; 20(4):767-80. PubMed ID: 1388181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
    Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
    J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention.
    Huczek Z; Kochman J; Filipiak KJ; Horszczaruk GJ; Grabowski M; Piatkowski R; Wilczynska J; Zielinski A; Meier B; Opolski G
    J Am Coll Cardiol; 2005 Jul; 46(2):284-90. PubMed ID: 16022956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty.
    de Groote P; Bauters C; McFadden EP; Lablanche JM; Leroy F; Bertrand ME
    Circulation; 1995 Feb; 91(4):968-72. PubMed ID: 7850983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
    Gibson CM; Goel M; Cohen DJ; Piana RN; Deckelbaum LI; Harris KE; King SB
    J Am Coll Cardiol; 1998 Jul; 32(1):28-34. PubMed ID: 9669245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.